Spero Therapeutics, Inc. (SPRO)
1.17
-0.05
(-4.10%)
USD |
NASDAQ |
Oct 21, 16:00
1.175
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics Net Income (Annual) : 8.572M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 8.572M |
| December 31, 2024 | -68.57M |
| December 31, 2023 | 22.81M |
| December 31, 2022 | -46.42M |
| December 31, 2021 | -89.76M |
| December 31, 2020 | -78.28M |
| Date | Value |
|---|---|
| December 31, 2019 | -60.92M |
| December 31, 2018 | -41.66M |
| December 31, 2017 | -39.89M |
| December 31, 2016 | -32.64M |
| December 31, 2015 | -13.15M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Inovio Pharmaceuticals, Inc. | -84.95M |
| Fortress Biotech, Inc. | -32.92M |
| Kura Oncology, Inc. | -278.67M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |